HIF1A and age-related macular degeneration: We also tested the consequences of a simultaneous ablation of Hif1a and Hif2a in cones to further explore safety aspects of potential therapies aiming to temper the HIF-response for the treatment of AMD and other retinal diseases with a hypoxic component.